Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review

This systematic review aimed to assess the efficacy of sildenafil in the treatment of pulmonary hypertension (PH) in dogs and, when possible, to propose recommendations for or against its use. Electronic searches were carried out using six international databases. The inclusion criterion was in vivo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Silva,AC, Oberlender,G, Mantovani,MM, Muzzi,RAL, Pereira,LJ, Zangeronimo,MG
Lenguaje:English
Publicado: Facultad de Ciencias Veterinarias, Universidad Austral de Chile 2014
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0301-732X2014000200014
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0301-732X2014000200014
record_format dspace
spelling oai:scielo:S0301-732X20140002000142014-09-11Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic reviewSilva,ACOberlender,GMantovani,MMMuzzi,RALPereira,LJZangeronimo,MG canine pulmonary disease therapy sildenafil This systematic review aimed to assess the efficacy of sildenafil in the treatment of pulmonary hypertension (PH) in dogs and, when possible, to propose recommendations for or against its use. Electronic searches were carried out using six international databases. The inclusion criterion was in vivo clinical trials that assessed the efficacy of sildenafil in the treatment of naturally occurring PH. The scoring system was designed to take into account aspects such as the form of distribution and masking of experimental treatments, the number of animals, association with other drugs, diagnostic methods for PH, evaluations of the clinical response to treatment and adverse effects. A total of five papers were found. In general, the clinical condition and quality of life of the animals improved after sildenafil therapy, and the occurrence of adverse effects was uncommon. Echocardiographic findings provided evidence for changes in pulmonary arterial pressure which could be associated with alterations in physical activity and survival time. Still, the methodological quality of the studies was low, only one of them was a randomised, placebo-controlled and double-blind clinical trial. Furthermore, with modest evidence, this study allowed the recommendation that sildenafil is an important therapy which can play a positive therapeutic role in the treatment of canine PH. Additionally, prospective, randomised, blinded and controlled studies with a larger number of animals assessing physical activity and the adverse effects of sildenafil and other drugs in association are recommended to evaluate the efficacy of this drug in dogs.info:eu-repo/semantics/openAccessFacultad de Ciencias Veterinarias, Universidad Austral de ChileArchivos de medicina veterinaria v.46 n.2 20142014-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0301-732X2014000200014en10.4067/S0301-732X2014000200014
institution Scielo Chile
collection Scielo Chile
language English
topic canine
pulmonary disease
therapy
sildenafil
spellingShingle canine
pulmonary disease
therapy
sildenafil
Silva,AC
Oberlender,G
Mantovani,MM
Muzzi,RAL
Pereira,LJ
Zangeronimo,MG
Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
description This systematic review aimed to assess the efficacy of sildenafil in the treatment of pulmonary hypertension (PH) in dogs and, when possible, to propose recommendations for or against its use. Electronic searches were carried out using six international databases. The inclusion criterion was in vivo clinical trials that assessed the efficacy of sildenafil in the treatment of naturally occurring PH. The scoring system was designed to take into account aspects such as the form of distribution and masking of experimental treatments, the number of animals, association with other drugs, diagnostic methods for PH, evaluations of the clinical response to treatment and adverse effects. A total of five papers were found. In general, the clinical condition and quality of life of the animals improved after sildenafil therapy, and the occurrence of adverse effects was uncommon. Echocardiographic findings provided evidence for changes in pulmonary arterial pressure which could be associated with alterations in physical activity and survival time. Still, the methodological quality of the studies was low, only one of them was a randomised, placebo-controlled and double-blind clinical trial. Furthermore, with modest evidence, this study allowed the recommendation that sildenafil is an important therapy which can play a positive therapeutic role in the treatment of canine PH. Additionally, prospective, randomised, blinded and controlled studies with a larger number of animals assessing physical activity and the adverse effects of sildenafil and other drugs in association are recommended to evaluate the efficacy of this drug in dogs.
author Silva,AC
Oberlender,G
Mantovani,MM
Muzzi,RAL
Pereira,LJ
Zangeronimo,MG
author_facet Silva,AC
Oberlender,G
Mantovani,MM
Muzzi,RAL
Pereira,LJ
Zangeronimo,MG
author_sort Silva,AC
title Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
title_short Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
title_full Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
title_fullStr Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
title_full_unstemmed Efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
title_sort efficacy of sildenafil therapy for pulmonary hypertension in dogs: a systematic review
publisher Facultad de Ciencias Veterinarias, Universidad Austral de Chile
publishDate 2014
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0301-732X2014000200014
work_keys_str_mv AT silvaac efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
AT oberlenderg efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
AT mantovanimm efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
AT muzziral efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
AT pereiralj efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
AT zangeronimomg efficacyofsildenafiltherapyforpulmonaryhypertensionindogsasystematicreview
_version_ 1718437934374322176